Corona Remedies Ltd (CORONA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039887, "name": "Corona Remedies", "stock_name": "Corona Remedies", "full_name": "Corona Remedies Ltd", "name_url": "stocks-analysis/corona-remedies", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,863.50", "chg": 30.85, "chgp": "1.68%", "dir": 1, "prev_price": "1,832.65", "mcapval": "11,309.00 Cr", "mcap": "Small Cap", "scripcode": 544644, "symbol": "CORONA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE02ZQ01018", "curr_date": "Jun 19, 03:30 PM", "curr_time": "22:19 PM", "last_traded_at": "Jun 19, 03:30 PM IST", "bse_nse_vol": "47.99 k", "exc_status": "Active", "traded_date": "Jun 19, 2026", "traded_date_str": "2026 06 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/corona-remedies-10039887-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Corona Remedies Ltd Gains 7.82%: 5 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-gains-782-5-key-factors-driving-the-weeks-momentum-4064899", "imagepath": "", "date": "2026-06-20 09:00:54", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Jun:</strong> Technical momentum shifts signal mild bullish outlook</p>\n <p><strong>16 Jun:</strong> Momentum shifts amid sideways trend</p>\n <p><strong>17 Jun:</strong> New 52-week high at Rs.2,097.35 and upper circuit hit</p>\n <p><strong>19 Jun:</strong> Quality grade upgraded to Excellent and Mojo rating raised to Hold</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,727.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..." }, { "title": "Corona Remedies Ltd Upgraded to Hold by MarketsMOJO on Strengthened Fundamentals and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-upgraded-to-hold-by-marketsmojo-on-strengthened-fundamentals-and-technicals-4062779", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_mojoScore_4062779.png", "date": "2026-06-19 08:18:00", "description": "Corona Remedies Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements in its quality metrics and technical outlook. The pharmaceutical company’s enhanced fundamentals, coupled with a shift to a mildly bullish technical trend, have prompted analysts to revise their stance, signalling cautious optimism for investors amid a challenging sector backdrop." }, { "title": "Corona Remedies Ltd Upgrades Quality Grade to Excellent Amid Strong Financial Metrics", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-upgrades-quality-grade-to-excellent-amid-strong-financial-metrics-4062528", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_qualitydot_4062528.png", "date": "2026-06-19 08:00:06", "description": "Corona Remedies Ltd has seen a significant upgrade in its quality grading from good to excellent, reflecting marked improvements in its core business fundamentals. The pharmaceutical company’s enhanced return ratios, robust debt management, and consistent operational performance have contributed to this positive reassessment, positioning it favourably within the Pharmaceuticals & Biotechnology sector." }, { "title": "Corona Remedies Ltd Locks at Upper Circuit With 3.91% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-hits-upper-circuit-amid-strong-buying-pressure-and-volatility-4058707", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_stocks_hitting_upper_circuit_4058707.png", "date": "2026-06-17 10:01:44", "description": "At Rs 2100.7, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Corona Remedies Ltd locked at its upper circuit of 3.91% on 17 Jun 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2097.35", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-hits-new-52-week-high-at-rs209735-4058585", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_priceRelatedfactors_4058585.png", "date": "2026-06-17 09:57:41", "description": "Surging to an all-time high of Rs 2097.35 on 17 Jun 2026, Corona Remedies Ltd has demonstrated robust price momentum, outpacing its sector and marking a significant milestone in its trading history." }, { "title": "Corona Remedies Ltd Technical Momentum Shifts Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-amid-mixed-market-returns-4058312", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_technicaldot_4058312.png", "date": "2026-06-17 08:07:10", "description": "Corona Remedies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite mixed short-term returns relative to the Sensex, the pharmaceutical and biotechnology company’s technical indicators suggest a cautiously optimistic outlook for investors." }, { "title": "Corona Remedies Ltd Technical Momentum Shifts Amid Sideways Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-amid-sideways-trend-4055281", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_technicaldot_4055281.png", "date": "2026-06-16 08:08:14", "description": "Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is reflected in key technical indicators such as MACD, RSI, and moving averages, signalling a period of consolidation after recent gains despite the stock’s strong year-to-date performance." }, { "title": "Corona Remedies Ltd Technical Momentum Shifts Signal Mild Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-4053638", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_technicaldot_4053638.png", "date": "2026-06-15 08:06:01", "description": "Corona Remedies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by a combination of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a potential uptrend for the small-cap pharmaceutical player amid a mixed market backdrop." }, { "title": "Corona Remedies Gains 2.88%: Mixed Technical Signals and Downgrade Shape Weekly Moves", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-gains-288-mixed-technical-signals-and-downgrade-shape-weekly-moves-4051707", "imagepath": "", "date": "2026-06-13 15:01:43", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Stock opens at Rs.1,684.00, Sensex down 0.96%</p>\n <p><strong>2 June:</strong> Mojo Grade downgraded to Sell; stock closes at Rs.1,698.25 (+0.85%)</p>\n <p><strong>3 June:</strong> Technical momentum shifts to sideways; stock dips slightly to Rs.1,696.85 (-0.08%)</p>\n <p><strong>5 June:</strong> Stock rallies to Rs.1,722.75 (+1.22%) despite Sensex decline</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,674.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-..." } ], "total": 25, "sid": "10039887", "stock_news_url": "https://www.marketsmojo.com/news/corona-remedies-10039887" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "16-Jun-2026", "details": "Newspaper Publication - Notice of 22nd Annual General Meeting Intimation of Record Date and E-voting information", "source": "BSE" }, { "caption": "Notice Of 22Nd Annual General Meeting", "datetime": "15-Jun-2026", "details": "Notice of 22nd Annual General Meeting scheduled to be held on Thursday July 09 2026", "source": "BSE" }, { "caption": "Regulation 34(1)-Annual Report", "datetime": "15-Jun-2026", "details": "Annual Report for the F.Y. 2025-26", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Corona Remedies Ltd has declared <strong>100%</strong> dividend, ex-date: 19 Jun 26", "dt": "2026-06-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

15 Jun: Technical momentum shifts signal mild bullish outlook

16 Jun: Momentum shifts amid sideways trend

17 Jun: New 52-week high at Rs.2,097.35 and upper circuit hit

19 Jun: Quality grade upgraded to Excellent and Mojo rating raised to Hold

Read full news article

Corona Remedies Ltd Upgraded to Hold by MarketsMOJO on Strengthened Fundamentals and Technicals

2026-06-19 08:18:00

Corona Remedies Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements in its quality metrics and technical outlook. The pharmaceutical company’s enhanced fundamentals, coupled with a shift to a mildly bullish technical trend, have prompted analysts to revise their stance, signalling cautious optimism for investors amid a challenging sector backdrop.

Read full news article

Corona Remedies Ltd Upgrades Quality Grade to Excellent Amid Strong Financial Metrics

2026-06-19 08:00:06

Corona Remedies Ltd has seen a significant upgrade in its quality grading from good to excellent, reflecting marked improvements in its core business fundamentals. The pharmaceutical company’s enhanced return ratios, robust debt management, and consistent operational performance have contributed to this positive reassessment, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Corona Remedies Ltd Locks at Upper Circuit With 3.91% Gain — Buyers Queue, Sellers Absent

2026-06-17 10:01:44

At Rs 2100.7, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Corona Remedies Ltd locked at its upper circuit of 3.91% on 17 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2097.35

2026-06-17 09:57:41

Surging to an all-time high of Rs 2097.35 on 17 Jun 2026, Corona Remedies Ltd has demonstrated robust price momentum, outpacing its sector and marking a significant milestone in its trading history.

Read full news article

Corona Remedies Ltd Technical Momentum Shifts Amid Mixed Market Returns

2026-06-17 08:07:10

Corona Remedies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite mixed short-term returns relative to the Sensex, the pharmaceutical and biotechnology company’s technical indicators suggest a cautiously optimistic outlook for investors.

Read full news article

Corona Remedies Ltd Technical Momentum Shifts Amid Sideways Trend

2026-06-16 08:08:14

Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is reflected in key technical indicators such as MACD, RSI, and moving averages, signalling a period of consolidation after recent gains despite the stock’s strong year-to-date performance.

Read full news article

Corona Remedies Ltd Technical Momentum Shifts Signal Mild Bullish Outlook

2026-06-15 08:06:01

Corona Remedies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by a combination of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a potential uptrend for the small-cap pharmaceutical player amid a mixed market backdrop.